Dr. Nicholas Farina, MD

Dr. Farina practices at CarolinaEast Internal Medicine - Pollocksville in Pollocksville, North Carolina.

Dr. Farina's NPI, 1013901164, was assigned on September 6, 2005. Dr. Farina graduated from Albert Einstein College of Medicine of Yeshiva University in 1995. Dr. Farina holds North Carolina license 9801252.

Dr. Farina's primary practice is CarolinaEast Internal Medicine - Pollocksville, at 137 Medical Lane, Pollocksville, NC 28573. The practice phone is (252) 635-3849.

Dr. Farina's primary practice is CarolinaEast Internal Medicine - Pollocksville in Pollocksville, North Carolina. Dr. Farina is also affiliated with CarolinaEast Medical Center. The medical group on file is Select Physical Therapy. Dmand AI also links Dr. Farina to 1 more hospital, 4 group practices and clinics, 3 medical groups, 2 home health agencies and 1 hospice, each named with a free account. Dr. Farina's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farina practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Farina's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Farina is licensed in North Carolina.

CMS data shows 9,237 Medicare services from Dr. Farina across 46 procedure codes in 2024, for 480 Medicare patients. Medicare paid $230,136 for them. Every service was in an office.

CMS counts 480 Medicare patients who saw Dr. Farina in 2024. The largest group is 75 to 84, with 205 patients. 73% of them have high blood pressure, and 62% have high cholesterol. 9% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farina's median patient age at 73, with 59% women.

In 2024, Dr. Farina wrote 12,540 Medicare Part D claims for 538 patients. 85% of them were for generic drugs. CMS names the drug for 11,817 of them, across 143 drugs with 11 or more claims each, at $1,068,890 in total drug cost. In 2023, CMS named 9,054 claims across 127 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Farina for performance year 2024, reported as part of a group. Dr. Farina accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Farina, published from 2016 to 2022. 2016 was the busiest year, with 3. The most frequent topics are MicroRNAs, Cell Line, Tumor and Gene Expression Regulation, Neoplastic. Dr. Farina has published most often in J Cell Physiol. Dr. Farina's most frequent co-authors are Marie Elizabeth Wood, MD, Scott D. Perrapato, DO and Steven Ades, MD.

CMS Open Payments shows 267 general payments to Dr. Farina from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $1,127.

Dr. Farina graduated from Albert Einstein College of Medicine of Yeshiva University in 1995.